ANDOVER, Mass., April 20, 2021 /PRNewswire/ -- TransMedics Group,
Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company
that is transforming organ transplant therapy for patients with
end-stage lung, heart and liver failure, today announced that it
will release financial results for the first quarter after market
close on Tuesday, May 4, 2021. The
TransMedics management team will host a corresponding conference
call beginning at 4:30 p.m. ET /
1:30 p.m. PT.
Investors interested in listening to the conference call may do
so by dialing (866) 393-4306 for domestic callers or (763) 488-9145
for international callers, followed by Conference ID: 1172894. A
live and archived webcast of the event will be available on the
"Investors" section of the TransMedics website at
https://investors.transmedics.com/.
About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal
warm perfusion and assessment of donor organs for transplantation.
Headquartered in Andover,
Massachusetts, the company was founded to address the unmet
need for more and better organs for transplantation and has
developed technologies to preserve organ quality, assess organ
viability prior to transplant, and potentially increase the
utilization of donor organs for the treatment of end-stage heart,
lung, and liver failure.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/transmedics-to-report-first-quarter-2021-financial-results-on-may-4-2021-301273113.html
SOURCE TransMedics Group, Inc.